Clinical consensus conference: Survey on gram-positive bloodstream infections with a focus on staphylococcus aureus

Clinical Infectious Diseases

Volumn 48, Issue SUPPL. 4, 2009, Pages

  Naber, Christoph K ^a   Baddour, Larry M ^e   Giamarellos Bourboulis, Evangelos J ^h   Gould, Ian M ⁱ   Herrmann, Mathias ^b   Hoen, Bruno ^j   Karchmer, Adolf W ^f   Kobayashi, Yoshio ^k   Kozlov, Roman S ^l   Lew, Daniel ^m   Miro, Jose M ^o   Moellering Jr , Robert C ^f   Moreillon, Philippe ⁿ   Peters, Georg ^c   Rubinstein, Ethan ^p   Seifert, Harald ^d   Corey, G Ralph ^g  

^a West German Heart Center   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

^e Mayo Clinic   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

ⁱ ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^j University Medical Center of Besanc   (France)

^k KEIO UNIVERSITY HOSPITAL   (Japan)

^l SMOLENSK STATE MEDICAL UNIVERSITY   (Russian Federation)

^m GENEVA UNIVERSITY HOSPITALS   (Switzerland)

ⁿ UNIVERSITY OF LAUSANNE   (Switzerland)

^o UNIVERSITY OF BARCELONA   (Spain)

^p UNIVERSITY OF MANITOBA   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; DAPTOMYCIN; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; BACTERIAL ENDOCARDITIS; BACTERIUM IDENTIFICATION; BLOOD CULTURE; BLOODSTREAM INFECTION; CONFERENCE PAPER; GRAM POSITIVE INFECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PRIORITY JOURNAL; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS AUREUS; ATTITUDE TO HEALTH; BACTEREMIA; CONSENSUS DEVELOPMENT; GRAM POSITIVE BACTERIUM; HUMAN; ISOLATION AND PURIFICATION; QUESTIONNAIRE; STAPHYLOCOCCUS INFECTION;

BACTEREMIA; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; QUESTIONNAIRES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 65649149090     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/598185     Document Type: Conference Paper

References (31)

1. Gaynes R, Edwards JR. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005; 41:848-54.
2. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991; 91:72S-5S.
3. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005; 26:166-74.
4. Lodise TP, McKinnon PS. Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia. Diagn Microbiol Infect Dis 2005; 52:113-22.
5. Reed SD, Friedman JY, Engemann JJ, et al. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin- susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2005; 26:175-83.
6. Health Protection Agency. Polymicrobial bacteraemias and fungaemias in England, Wales, and Northern Ireland: 2007. Available at: http://www.hpa.org.uk/ web/HPAwebFile/HPAweb-C/1213946128496. Accessed 5 January 2009.
7. Mitchell DH, Howden BP. Diagnosis and management of Staphylococcus aureus bacteraemia. Intern Med J 2005; 35(Suppl 2):S17-24.
8. O'Grady NP, Barie PS, Bartlett JG, et al. Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America. Crit Care Med 2008; 36:1330-49.
9. Beekmann SE, Diekema DJ, Doern GV. Determining the clinical significance of coagulase-negative staphylococci isolated from blood cultures. Infect Control Hosp Epidemiol 2005; 26:559-66.
10. Dobbins BM, Kite P, Kindon A, McMahon MJ, Wilcox MH. DNA fingerprinting analysis of coagulase negative staphylococci implicated in catheter related bloodstream infections. J Clin Pathol 2002; 55:824-8.
11. Povoa P, Coelho L, Almeida E, et al. Pilot study evaluating C-reactive protein levels in the assessment of response to treatment of severe bloodstream infection. Clin Infect Dis 2005; 40:1855-7.
12. Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review andmetaanalysis. Lancet Infect Dis 2007; 7:210-7.
13. Schuetz P, Christ-Crain M, Wolbers M, et al. Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.BMC Health Serv Res 2007; 7:102.
14. Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 2008; 36:941-52.
15. Mylotte JM, Tayara A. Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis 2000; 31:1170-4.
16. Khatib R, Riederer K, Saeed S, et al. Time to positivity in Staphylococcus aureus bacteremia: possible correlation with the source and outcome of infection. Clin Infect Dis 2005; 41:594-8.
17. Jensen AG, Wachmann CH, Espersen F, Scheibel J, Skinhoj P, Frimodt- Moller N. Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases. Arch Intern Med 2002; 162:25-32.
18. Lodise TP, McKinnon PS, Swiderski L, Rybak MJ. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003; 36:1418-23.
19. Khatib R, Saeed S, Sharma M, Riederer K, Fakih MG, Johnson LB. Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 2006; 25:181-5. 20. Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998; 244:379-86.
20. Gemmell CG, Edwards DI, Fraise AP, Gould FK, Ridgway GL, Warren RE. Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J Antimicrob Chemother 2006; 57:589-608.
21. Chang FY, Peacock JE Jr, Musher DM, et al. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore) 2003; 82:333-9.
22. Stryjewski ME, Szczech LA, Benjamin DK Jr, et al. Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysisdependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis 2007; 44:190-6.
23. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005; 41:1373-406.
24. Dandache P, Aronow WS, Sakoulas G. Clinical update on the diagnosis and treatment of bacterial endocarditis. Compr Ther 2007; 33:192-207.
25. Arbeit RD, Maki D, Tally FP, Campanaro E, Eisenstein BI. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin Infect Dis 2004; 38:1673-81.
26. Fowler VG Jr, Boucher HW, Corey GR, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006; 355:653-65.
27. Fowler VG Jr, Olsen MK, Corey GR, et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 2003; 163: 2066-72.
28. Johnson LB, Almoujahed MO, Ilg K, Maolood L, Khatib R. Staphylococcus aureus bacteremia: compliance with standard treatment, longterm outcome and predictors of relapse. Scand J Infect Dis 2003; 35: 782-9.
29. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005; 111:e394-434.
30. Murray RJ. Staphylococcus aureus infective endocarditis: diagnosis and management guidelines. Intern Med J 2005; 35(Suppl 2):S25-44.
31. Rosen AB, Fowler VG Jr, Corey GR, et al. Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia. Ann Intern Med 1999; 130:810-20.